Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Infants will no longer receive hepatitis B vaccine at birth, CDC announces- Tech Devices 2023: The Most blazing Arrivals of the Year
- Pick Your Favored kind of books
- These four astronauts could soon travel farther from Earth than anyone has gone before
- The Force of Mentorship: Self-improvement through Direction
- 2024 Moving Styles for Kitchen Redesigns
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
